Plasmodium vivax is the second most prevalent cause of malaria worldwide and the leading
cause of malaria outside of Africa. Although infections are seldom fatal clinical disease can …

Across the Americas and the Caribbean, nearly 561,000 slide-confirmed malaria infections
were reported officially in 2008. The nine Amazonian countries accounted for 89% of these …

Malaria in Peru, dominated by Plasmodium vivax, remains a public health problem. The
1990s saw newly epidemic malaria emerge, primarily in the Loreto Department in the …

Traditionally, infection with Plasmodium vivax was thought to be benign and self-limiting,
however, recent evidence has demonstrated that infection with P. vivax can also result in …

Plasmodium vivax, one of the five species of Plasmodium parasites that cause human
malaria, is responsible for 25–40% of malaria cases worldwide. Malaria global elimination …

Background Although malaria control investments worldwide have resulted in dramatic
declines in transmission since 2000, progress has stalled. In the Amazon, malaria …

Plasmodium vivax is the most prevalent human malaria parasite in the Americas. Previous
studies have contrasted the genetic diversity of parasite populations in the Americas with …

Malaria has steadily increased in the Peruvian Amazon over the last five years. This study
aimed to determine the parasite prevalence and micro-geographical heterogeneity of …

Approximately 170 million inhabitants of the American continent live at risk of malaria
transmission. Although the continent's contribution to the global malaria burden is small, at …

Background Plasmodium vivax infections are an important contributor to the malaria burden
worldwide. The World Health Organization recommends a 14‐day course of primaquine …